SYNDROS is a Oral Solution in the Human Prescription Drug category. It is labeled and distributed by Benuvia Therapeutics Inc.. The primary component is Dronabinol.
Product ID | 78613-201_47babd53-3b15-4b73-ab66-32d4b304bb6b |
NDC | 78613-201 |
Product Type | Human Prescription Drug |
Proprietary Name | SYNDROS |
Generic Name | Dronabinol |
Dosage Form | Solution |
Route of Administration | ORAL |
Marketing Start Date | 2017-07-01 |
Marketing Category | NDA / NDA |
Application Number | NDA205525 |
Labeler Name | Benuvia Therapeutics Inc. |
Substance Name | DRONABINOL |
Active Ingredient Strength | 5 mg/mL |
Pharm Classes | Cannabinoid [EPC],Cannabinoids [CS] |
DEA Schedule | CII |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2017-07-01 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
20482-335 | SYNDROS | SYNDROS |
78613-201 | SYNDROS | SYNDROS |
0527-1450 | Dronabinol | Dronabinol |
0527-1451 | Dronabinol | Dronabinol |
0527-1452 | Dronabinol | Dronabinol |
0527-4125 | DRONABINOL | dronabinol |
0591-3591 | Dronabinol | Dronabinol |
0591-3592 | Dronabinol | Dronabinol |
0591-3593 | Dronabinol | Dronabinol |
0904-6597 | Dronabinol | Dronabinol |
0904-6598 | Dronabinol | Dronabinol |
0904-6745 | DRONABINOL | DRONABINOL |
0904-6746 | DRONABINOL | DRONABINOL |
0904-7068 | Dronabinol | Dronabinol |
0904-7144 | Dronabinol | Dronabinol |
0904-7145 | Dronabinol | Dronabinol |
17478-761 | Dronabinol | Dronabinol |
17478-762 | Dronabinol | Dronabinol |
17478-763 | Dronabinol | Dronabinol |
0051-0021 | Marinol | Dronabinol |
0051-0022 | Marinol | Dronabinol |
0051-0023 | Marinol | Dronabinol |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
SYNDROS 86360360 5286618 Live/Registered |
FRESH CUT DEVELOPMENT, LLC 2014-08-07 |